Self-perceived Health Status and Healthcare Consumption of Idiopathic Scoliosis Patients Treated More Than 20 Years Ago: How Much do Operated and Non-operated Patients Differ?
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Jun 22, 2023
Trial Information
Current as of August 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients with adolescent idiopathic scoliosis (AIS) feel about their health and how often they need medical care more than 20 years after their treatment. AIS is a condition where the spine curves abnormally, which can cause issues with the appearance of the back and shoulders. The study aims to compare the long-term health of patients who had surgery to correct their scoliosis with those who did not have surgery, to better understand how these treatments affect people over time.
To be eligible for this study, participants need to have been diagnosed with AIS and had a significant curvature of their spine (over 40 degrees) when they were treated as teenagers (ages 10 to 18). They also need to have been followed for more than 20 years and still be reachable for the study. Participants will fill out questionnaires about their health and healthcare needs, which will help researchers learn more about the effectiveness of different treatment options and improve future care for young patients with scoliosis.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosis of Adolescent Idiopathic Scoliosis
- • Main baseline curve magnitude over 40º
- • Aged 10 to 18 years at the time of treatment (surgical or nonsurgical)
- • More than 20 years of follow up
- • Current contact information available
- Exclusion Criteria:
- • Non-idiopathic scoliosis
- • Younger than 10 or older than 18 at the time of initial treatment
- • Less than 20 years of follow up
- • Patients unable to understand and answer the questionnaires because of language difficulties or because of cognitive impairments
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bruges, , France
Strasbourg, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported